[1] CHO JH, KIM JM, RO WY, et al. Three cases of Fibrous Dysplasia involving the paranasal sinuses. Korean J Otolaryngol-Head Neck Surg. 1999;42(10):1316-1320.
[2] BHADADA SK, PAL R, SOOD A, et al. Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy.Front Endocrinol (Lausanne). 2019;10:803.
[3] HAN I, ChOI ES, KIM HS. Monostotic fibrous dysplasia of the proximal femur:natural history and predisposing factors for disease progression.Bone Joint J.2014;96B:673-676.
[4] GOISIS M, BIGLOILI F, GUARESCHI M, et al. Fibrous dysplasia of the orbital region: current clinical perspectives in ophthalmology and craniomaxillofacial surgery.Ophthal Plast Reconstr Surg.2006;22(5): 383-387.
[5] DAL CP, SCIOT R, BIYS P, et al. Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. Chromosomes and Morphology.Cancer Genet Cytogenet. 2000; 122(1):30-32.
[6] DICAPRIO MR, ENNEKING WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment.J Bone Joint Surg Am.2005;87(8):1848-1864.
[7] STANTON RP, IPPOLITO E, SPRINGFIELD D, et al. The surgical management of fibrous dysplasia of bone.Orphanet J Rare Dis.2012;7 Suppl 1:S1.
[8] ABA EIFATTAH H, HELEM Y, EIKHOLY B, et al. In vivo animal histo-Omorphometrie study for evaluating biocompatibility and osteointe-gration of nano-hydroxyapatite as biomaterials in tissue engineering.Egypat Natl Canc lust.2010;22(4):241-250.
[9] RATNER B, HOFFMAN AS, SCHOEN FI, et al. Biomaterials Science: an Introduction to Materials in Medicine.San Diego:Academic Press, 2004: 162-164.
[10] WANG X, LI Y, WEI J, et al. Development of biomimetic nano-hydroxyapatite/poly(hexamethylene adipamide) composites.Biomaterials. 2002;23(24):4787-4791.
[11] WANG H, LI Y, ZUO Y, et al. Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering.Biomaterials. 2007;28(22):3338-3348.
[12] YANG AP, LI H, LI JD, et al. Fabrication of porous n-HA/PA66 composite for bone repair.Key Eng Mater.2007;330:321-324.
[13] BAJWAA MS, ETHUNANDAN M, FLOOD TR. Oral rehabilitation with endosseous implants in a patient with fibrous dysplasia (McCune-Albright syndrome) : a case report.J Oral Maxillofac Surg. 2008; 66(12):2605-2608.
[14] LANE JM, SANDHU HS. Current approaches to experimental bone grafting. The Orthop Clin North Am.1987;18(2):213-225.
[15] GIANNOUDIS PV, DINOPOULOS H, TSIRIDIS E. Bone substitutes: an update. Injury.2005;36(Suppl 3):S20-S27.
[16] CRUZ DM, GOMES M, REIS RL, et al. Differentiation of mesenchymal stem cells in chitosann with double micro and macroporosity.Biomed Mater Res.2010;95A(4):1182-1193.
[17] MOORE WR, GRAVES SE, BAIN GI. Synthetic bone graft substitutes.ANZ J Surg.2001;71(6):354-361.
[18] CAI YZ, WANG LL, CAI HX, et al. Electrospun nanofibrous matrix improves the regeneration of dense cortical bone.J Biomed Mater Res A. 2010;95(1):49-57.
[19] ENNEKING WF, DANHAM W, GEBHAMDT MC, et al. A system for the functional evaluation of reconstruction procedures after surgical treatment of tumors of the musculo skeletal systeme. Clin Orthop. 1993;286:241-246.
[20] XIONG Y, REN C, ZHANG B, et al. Analyzing the behavior of a porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite for healing of bone defects.Int J Nanomedicine.2014;9:485-494.
[21] ZHANG Y, DENG X, JIANG DM, et al. Long-term results of anterior cervical corpectomy and fusion with nano-hydroxyapatite/polyamide 66 strut for cervical spondylotic myelopathy.Sci Rep.2016;6:26751.
[22] WANG Y, WANG O, JIANG Y, et al. Efficacy and safety of bisphosphonate therapy in McCune-Albright syndrome–related polyostotic fibrous dysplasia: a single-center experience.Endocr Pract.2019; 25:23-30.
[23] STANTON RP, DIAMOND L. Surgical management of fibrous dysplasia in McCune-Albright syndrome. Pediatr Endocrinol Rev.2007;4(Suppl 4): 446-452.
[24] 陈鹏,吴学建,朱旭,等.髓内钉支撑并组织工程化骨填塞治疗股骨近端骨纤维异常增殖症[J].中国组织工程研究,2014,18(4): 589-594.
[25] ZOU Q, LI J, NIU L, et al. Modified n-HA/PA66 scaffolds with chitosan coating for bone tissue engineering: cell stimulation and drug release.J Biomater Sci Polym Ed.2017;28(13):1271-1285.
[26] MOZAFARI M, GHOLIPOURMALEKABADI M, CHAUHAN NP, et al. Synthesis and characterization of nanocrystalline forsterite coated poly(L-lactide-co-beta-malic acid) scaffolds for bone tissue engineering applications.Mater Sci Eng C Mater Biol Appl.2015;50:117-123.
[27] KIM HM, FURUYA T, KOKUBO T, et al. Composition of apatite produced in simulated body fluids. Key Eng Mater.2001;11:218-220.
[28] ZHONG W, LIANG X, TANG K, et al. Nano hydroxyapatite/polyamide 66 strut subsidence after onelevel corpectomy: underlying mechanism and effect on cervical neurological function.Sci Rep.2018;8:12098.
[29] WU J, LUO D, YE X, et al. Anatomy-related risk factors for the subsidence of titanium mesh cage in cervical reconstruction after one-level corpectomy.Int J Clin Exp Med.2015;8(5):7405-7411.
[30] 杨明敏,李黛,孙扬.纳米羟基磷灰石复合聚酰胺66材料修复早期股骨头坏死[J].中国组织工程研究,2015,19(34):5463-5467.
[31] CHANG BS, LEE CK, HONG KS, et al. Osteoconduction at porous hydroxyapatite with various pore configurations.Biomaterials. 2000; 21(12):1291-1298.
[32] JIE W, YUBAO L. Tissue engineering scaffold material of nano-apatite crystals and polyamide composite.Eur Polym J.2004;40(3):509-515.
[33] HOUWING RH, ROZENDAAL M, WOUTERS-WESSELING W, et al. A randomized double-blind assessment of the effect of nutritional supplementation on the prevention of pressure ulcers in hip-fracture patients.Clin Nutr.2013;22(4):401-405.
[34] XU Q, LU HY, ZHANG JC, et al. Tissue engineering scaffold material of porous nanohydroxyapatite/polyamide 66.Int J Nanomedicine. 2010; 5:331-335.
[35] 刘怀浩,张利,左奕,等.脂肪族聚氨酯/磷灰石复合材料的原位制备和性能[J].功能材料,2010, 41(2):241-244.
[36] TSUCHIYA T. Studies on the standardization of cytotoxicity tests and new standard reference materials useful for evaluating the safety of biomaterials. J Biomater Appl.1994;9(2):138-157. |